• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经血管控制失调是有肝纤维化风险的非酒精性脂肪性肝病(NAFLD)患者微血管功能下降的潜在原因。

Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis.

作者信息

Clough Geraldine F, Chipperfield Andrew J, Thanaj Marjola, Scorletti Eleonora, Calder Philip C, Byrne Christopher D

机构信息

Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, United Kingdom.

出版信息

Front Physiol. 2020 Jun 3;11:551. doi: 10.3389/fphys.2020.00551. eCollection 2020.

DOI:10.3389/fphys.2020.00551
PMID:32581841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7283580/
Abstract

BACKGROUND/AIMS: Increasing evidence shows that non-alcoholic fatty liver disease (NAFLD) is associated with dysregulation of microvascular perfusion independently of established cardio-metabolic risk factors. We investigated whether hepatic manifestations of NAFLD such as liver fibrosis and liver fat are associated with microvascular hemodynamics through dysregulation of neurovascular control.

METHODS

Microvascular dilator (post-occlusive reactive hyperemia) and sympathetically mediated constrictor (deep inspiratory breath-hold) responses were measured at the forearm and finger, respectively, using laser Doppler fluximetry. Non-linear complexity-based analysis was used to assess the information content and variability of the resting blood flux (BF) signals, attributable to oscillatory flow-motion activity, and over multiple sampling frequencies.

RESULTS

Measurements were made in 189 adults (113 men) with NAFLD, with ( = 65) and without ( = 124) type 2 diabetes mellitus (T2DM), age = 50.9 ± 11.7 years (mean ± SD). Microvascular dilator and constrictor capacity were both negatively associated with age ( = -0.178, = 0.014, and = -0.201, = 0.007, respectively) and enhanced liver fibrosis (ELF) score ( = -0.155, = 0.038 and = -0.418, < 0.0001, respectively). There was no association with measures of liver fat, obesity or T2DM. Lempel-Ziv complexity (LZC) and sample entropy (SE) of the BF signal measured at the two skin sites were associated negatively with age ( < 0.01 and < 0.001) and positively with ELF score ( < 0.05 and < 0.0001). In individuals with an ELF score ≥7.8 the influence of both neurogenic and respiratory flow-motion activity on LZC was up-rated ( < 0.0001).

CONCLUSION

Altered microvascular network functionality occurs in adults with NAFLD suggesting a mechanistic role for dysregulated neurovascular control in individuals at risk of severe liver fibrosis.

摘要

背景/目的:越来越多的证据表明,非酒精性脂肪性肝病(NAFLD)与微血管灌注失调有关,且独立于已确定的心血管代谢危险因素。我们研究了NAFLD的肝脏表现,如肝纤维化和肝脂肪,是否通过神经血管控制失调与微血管血流动力学相关。

方法

分别使用激光多普勒血流仪在前臂和手指测量微血管扩张剂(闭塞后反应性充血)和交感神经介导的收缩剂(深吸气屏气)反应。基于非线性复杂度的分析用于评估静息血流(BF)信号的信息含量和变异性,这些信号归因于振荡血流运动活动,并涉及多个采样频率。

结果

对189名患有NAFLD的成年人(113名男性)进行了测量,其中有(n = 65)和没有(n = 124)2型糖尿病(T2DM),年龄为50.9±11.7岁(平均值±标准差)。微血管扩张剂和收缩剂能力均与年龄呈负相关(分别为r = -0.178,P = 0.014和r = -0.201,P = 0.007)以及与增强肝纤维化(ELF)评分呈负相关(分别为r = -0.155,P = 0.038和r = -0.418,P < 0.0001)。与肝脂肪、肥胖或T2DM的测量指标无关联。在两个皮肤部位测量的BF信号的Lempel-Ziv复杂度(LZC)和样本熵(SE)与年龄呈负相关(P < 0.01和P < 0.001),与ELF评分呈正相关(P < 0.05和P < 0.0001)。在ELF评分≥7.8的个体中,神经源性和呼吸性血流运动活动对LZC的影响均增强(P < 0.0001)。

结论

患有NAFLD的成年人存在微血管网络功能改变,提示神经血管控制失调在有严重肝纤维化风险的个体中起机制性作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5783/7283580/bb40a1d50eb9/fphys-11-00551-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5783/7283580/32d5386b80ef/fphys-11-00551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5783/7283580/bb40a1d50eb9/fphys-11-00551-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5783/7283580/32d5386b80ef/fphys-11-00551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5783/7283580/bb40a1d50eb9/fphys-11-00551-g004.jpg

相似文献

1
Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis.神经血管控制失调是有肝纤维化风险的非酒精性脂肪性肝病(NAFLD)患者微血管功能下降的潜在原因。
Front Physiol. 2020 Jun 3;11:551. doi: 10.3389/fphys.2020.00551. eCollection 2020.
2
Analysis of microvascular blood flow and oxygenation: Discrimination between two haemodynamic steady states using nonlinear measures and multiscale analysis.微血管血流和氧合分析:使用非线性测量和多尺度分析区分两种血液动力学稳态。
Comput Biol Med. 2018 Nov 1;102:157-167. doi: 10.1016/j.compbiomed.2018.09.026. Epub 2018 Sep 26.
3
Multi-domain analysis of microvascular flow motion dynamics in NAFLD.多域分析非酒精性脂肪性肝病中小血管血流运动动力学。
Microcirculation. 2019 Jul;26(5):e12538. doi: 10.1111/micc.12538. Epub 2019 Mar 26.
4
Enhanced flow-motion complexity of skin microvascular perfusion in Sherpas and lowlanders during ascent to high altitude.高原攀登过程中夏尔巴人和低地居民皮肤微血管血流复杂性增强。
Sci Rep. 2019 Oct 7;9(1):14391. doi: 10.1038/s41598-019-50774-0.
5
Peripheral vascular response to inspiratory breath hold in paediatric homozygous sickle cell disease.小儿纯合子镰状细胞病吸气屏气时外周血管反应。
Exp Physiol. 2013 Jan;98(1):49-56. doi: 10.1113/expphysiol.2011.064055. Epub 2012 Jun 1.
6
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.显著肝纤维化可预测 NASH 患者新发糖尿病和动脉高血压。
J Hepatol. 2020 Jul;73(1):17-25. doi: 10.1016/j.jhep.2020.02.028. Epub 2020 Mar 6.
7
Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.非酒精性脂肪性肝病与 2 型糖尿病患者和非糖尿病患者心脏自主神经平衡受损的关系——南蒂罗尔合作健康研究(CHRIS)-非酒精性脂肪性肝病亚研究。
Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3464-3473. doi: 10.1016/j.numecd.2021.08.037. Epub 2021 Aug 24.
8
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.非酒精性脂肪性肝炎与非肝硬化患者亚临床心肌功能障碍的相关性。
J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24.
9
Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.非酒精性脂肪性肝病相关肝纤维化与 2 型糖尿病或糖调节受损绝经后妇女骨密度的关系。
BMJ Open Diabetes Res Care. 2020 Aug;8(1). doi: 10.1136/bmjdrc-2019-000999.
10
Microvascular reactivity in women with gestational diabetes mellitus studied during pregnancy.妊娠期糖尿病女性孕期微血管反应性的研究。
Diabetol Metab Syndr. 2015 Mar 28;7:27. doi: 10.1186/s13098-015-0017-4. eCollection 2015.

引用本文的文献

1
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
2
The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity.21 世纪的交感神经系统:代谢稳态和肥胖中的神经免疫相互作用。
Neuron. 2022 Nov 2;110(21):3597-3626. doi: 10.1016/j.neuron.2022.10.017.

本文引用的文献

1
NAFLD as a driver of chronic kidney disease.非酒精性脂肪性肝病作为慢性肾脏病的一个驱动因素。
J Hepatol. 2020 Apr;72(4):785-801. doi: 10.1016/j.jhep.2020.01.013. Epub 2020 Feb 12.
2
Multiscale, multidomain analysis of microvascular flow dynamics.微血管流动动力学的多尺度、多领域分析。
Exp Physiol. 2020 Sep;105(9):1452-1458. doi: 10.1113/EP087874. Epub 2020 Feb 7.
3
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis.用于肝纤维化检测和预后的标准化增强肝纤维化(ELF)检测阈值的推导与性能
J Appl Lab Med. 2019 Mar;3(5):815-826. doi: 10.1373/jalm.2018.027359. Epub 2018 Oct 11.
4
Liver fibrosis by FibroScan independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes.通过FibroScan检测的肝纤维化独立于已确立的心血管风险参数,与2型糖尿病患者的大血管和微血管并发症相关。
Liver Int. 2020 Feb;40(2):347-354. doi: 10.1111/liv.14274. Epub 2019 Oct 31.
5
Liver sympathetic denervation reverses obesity-induced hepatic steatosis.肝交感神经去神经支配可逆转肥胖诱导的肝脂肪变性。
J Physiol. 2019 Sep;597(17):4565-4580. doi: 10.1113/JP277994. Epub 2019 Jul 26.
6
A new approach to the analysis of skin blood flow oscillations in human.一种新的分析人体皮肤血流振荡的方法。
Microvasc Res. 2019 Nov;126:103889. doi: 10.1016/j.mvr.2019.103889. Epub 2019 Jun 27.
7
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.CT 检查的非酒精性脂肪肝与心肌灌注 PET/CT 检查的冠状动脉微血管功能障碍之间的关联。
Radiology. 2019 May;291(2):330-337. doi: 10.1148/radiol.2019181793. Epub 2019 Mar 5.
8
Multi-domain analysis of microvascular flow motion dynamics in NAFLD.多域分析非酒精性脂肪性肝病中小血管血流运动动力学。
Microcirculation. 2019 Jul;26(5):e12538. doi: 10.1111/micc.12538. Epub 2019 Mar 26.
9
Analysis of microvascular blood flow and oxygenation: Discrimination between two haemodynamic steady states using nonlinear measures and multiscale analysis.微血管血流和氧合分析:使用非线性测量和多尺度分析区分两种血液动力学稳态。
Comput Biol Med. 2018 Nov 1;102:157-167. doi: 10.1016/j.compbiomed.2018.09.026. Epub 2018 Sep 26.
10
Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults.成人非酒精性脂肪性肝病的诊断与监测测试。
BMJ. 2018 Jul 12;362:k2734. doi: 10.1136/bmj.k2734.